How we manage autologous stem cell transplantation for patients with multiple myeloma.

Abstract:

:An estimated 22 350 patients had multiple myeloma diagnosed in 2013, representing 1.3% of all new cancers; 10 710 deaths are projected, representing 1.8% of cancer deaths. Approximately 0.7% of US men and women will have a myeloma diagnosis in their lifetime, and with advances in therapy, 77 600 US patients are living with myeloma. The 5-year survival rate was 25.6% in 1989 and was 44.9% in 2005. The median age at diagnosis is 69 years, with 62.4% of patients aged 65 or older at diagnosis. Median age at death is 75 years. The rate of new myeloma cases has been rising 0.7% per year during the past decade. The most common indication for autologous stem cell transplantation in the United States is multiple myeloma, and this article is designed to provide the specifics of organizing a transplant program for multiple myeloma. We review the data justifying use of stem cell transplantation as initial management in myeloma patients. We provide selection criteria that minimize the risks of transplantation. Specific guidelines on mobilization and supportive care through the transplant course, as done at Mayo Clinic, are given. A review of the data on tandem vs sequential autologous transplants is provided.

journal_name

Blood

journal_title

Blood

authors

Gertz MA,Dingli D

doi

10.1182/blood-2014-03-544759

subject

Has Abstract

pub_date

2014-08-07 00:00:00

pages

882-90

issue

6

eissn

0006-4971

issn

1528-0020

pii

blood-2014-03-544759

journal_volume

124

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.

    abstract::The human erythrocyte blood group system Cromer consists of high-incidence and low-incidence antigens that reside on decay-accelerating factor (DAF; CD55), a glycosyl-phosphatidylinositol-anchored membrane protein that regulates complement activation on cell surfaces. In the Cromer phenotypes Dr(a-) and Inab there is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lublin DM,Mallinson G,Poole J,Reid ME,Thompson ES,Ferdman BR,Telen MJ,Anstee DJ,Tanner MJ

    更新日期:1994-08-15 00:00:00

  • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

    abstract::The survival of patients with aggressive non-Hodgkin lymphoma (NHL) is increasing, but the incidence of secondary cancer and late toxicity is poorly defined for those treated with cyclophosphamide-hydroxydaunomycin/doxorubicin-Oncovin-prednisone (CHOP)-like chemotherapy. From February 1984 to January 1998, 2837 patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1124

    authors: André M,Mounier N,Leleu X,Sonet A,Brice P,Henry-Amar M,Tilly H,Coiffier B,Bosly A,Morel P,Haioun C,Gaulard P,Reyes F,Gisselbrecht C,Groupe D'Etude Des Lymphomes De L'Adulte.

    更新日期:2004-02-15 00:00:00

  • Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.

    abstract::The cellular immune defect in untreated Hodgkin's disease (HD) has long been recognized. This defect appears to be responsible for at least some of the morbidity and ultimately the mortality associated with the disease. In recent years, many studies have shown that the T cell component of the immune response is the ap...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ford RJ,Tsao J,Kouttab NM,Sahasrabuddhe CG,Mehta SR

    更新日期:1984-08-01 00:00:00

  • How to generate large numbers of CD103+ dendritic cells.

    abstract::In this issue of Blood, Mayer et al describe a new method of generating high numbers of Batf3- and Irf8-dependent CD103+ conventional dendritic cells (cDCs), providing new opportunities to study this subset of antigen-presenting cells specialized in crosspresentation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-08-595298

    authors: van de Laar L,Lambrecht BN

    更新日期:2014-11-13 00:00:00

  • Hematopoiesis in asymptomatic cats infected with feline immunodeficiency virus.

    abstract::Anemia and neutropenia often develop in cats that are infected with the feline immunodeficiency virus (FIV), a lentivirus biologically similar to the human immunodeficiency virus (HIV). To assess the role of FIV in the pathogenesis of these abnormalities, marrow culture studies were performed on nine asymptomatic, hem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Linenberger ML,Shelton GH,Persik MT,Abkowitz JL

    更新日期:1991-10-15 00:00:00

  • A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.

    abstract::Adult T-cell leukemia (ATL) is neoplasm of the mature helper T lymphocytes and human T-cell lymphotropic virus type-I (HTLV-I) has been shown to be causative virus of ATL. Because HTLV-I integrates its provirus randomly into host chromosomal DNA, monoclonal integration of HTLV-I provirus indicates the clonal prolifera...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Takemoto S,Matsuoka M,Yamaguchi K,Takatsuki K

    更新日期:1994-11-01 00:00:00

  • Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

    abstract::Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kjeldsen L,Bainton DF,Sengeløv H,Borregaard N

    更新日期:1994-02-01 00:00:00

  • CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells.

    abstract::Hyaluronan-binding function of the CD44 molecule has not been so far detected in myeloid cells. To study pure populations of primitive myeloid cells, we investigated the hyaluronan-binding function of the CD44 molecule from three myeloid cell lines: KG1a, KG1, and HL60. Both KG1a and KG1 cells express the CD34 antigen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morimoto K,Robin E,Le Bousse-Kerdiles MC,Li Y,Clay D,Jasmin C,Smadja-Joffe F

    更新日期:1994-02-01 00:00:00

  • Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload.

    abstract::We compared 48-hour urinary iron excretion after a twice-daily subcutaneous bolus injection of deferoxamine and after 12 hours of subcutaneous continuous infusion of the drug in 27 patients with iron overload (mean age, 55.7 years). In most patients, the iron overload was due to multiple transfusions administered duri...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Franchini M,Gandini G,de Gironcoli M,Vassanelli A,Borgna-Pignatti C,Aprili G

    更新日期:2000-05-01 00:00:00

  • Physical and functional association of Fc alpha R with protein tyrosine kinase Lyn.

    abstract::In this report, we show that the Src family nonreceptor protein tyrosine kinase (PTK) Lyn associates with aggregated IgA Fc receptor (Fc alpha R) in the monocytic cell line THP-1. Receptor aggregation and subsequent immunoprecipitation of receptor complexes with huIgA adsorbed to nitrocellulose particles shows that Ly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gulle H,Samstag A,Eibl MM,Wolf HM

    更新日期:1998-01-15 00:00:00

  • Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

    abstract::Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-601187

    authors: Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

    更新日期:2015-05-07 00:00:00

  • Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study.

    abstract::Interphase cytogenetics by means of in situ hybridization with the chromosome 12-specific biotinylated alpha satellite DNA probe pSP 12-1 was used for the study of trisomy 12, the most common chromosomal abnormality in chronic lymphocytic leukemia. In situ hybridization was performed on methanol/acetic acid fixed cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Losada AP,Wessman M,Tiainen M,Hopman AH,Willard HF,Solé F,Caballín MR,Woessner S,Knuutila S

    更新日期:1991-08-01 00:00:00

  • Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation.

    abstract::Mononuclear cell preparations from peripheral blood after mobilization with hematopoietic growth factors have been shown to induce accelerated neutrophil and platelet recovery as compared with that induced by autologous bone marrow transplantation after myeloablative chemotherapy. Because these mononuclear cell produc...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Ho AD,Maruyama M,Maghazachi A,Mason JR,Glück S,Corringham RE

    更新日期:1994-11-15 00:00:00

  • Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.

    abstract::Antiangiogenic agents and therapeutic strategies have entered the clinical oncology arena. The classical tumor size measurements defined to monitor efficacy of chemotherapy, however, might not be appropriate for these newer therapeutics. We previously found that circulating endothelial cells (CECs) were increased in n...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2005-11-4570

    authors: Mancuso P,Colleoni M,Calleri A,Orlando L,Maisonneuve P,Pruneri G,Agliano A,Goldhirsch A,Shaked Y,Kerbel RS,Bertolini F

    更新日期:2006-07-15 00:00:00

  • Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.

    abstract::The last 2 years have seen much excitement in the field of genetics with the identification of a formerly unappreciated level of "structural variation" within the normal human genome. Genetic structural variants include deletions, duplications, and inversions in addition to the recently discovered, copy number variant...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-06-030858

    authors: Mullally A,Ritz J

    更新日期:2007-02-15 00:00:00

  • Identification of T lymphocytes in human mixed hemopoietic colonies.

    abstract::The addition of a T-cell growth-promoting medium (PHA-TCM) to culture conditions that support growth of multi-lineage hemopoietic colonies enhances the proliferation of cells with lymphoid morphology within these colonies. These cells were identified as T lymphocytes by their ability to form rosettes with SRBC and the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Messner HA,Izaquirre CA,Jamal N

    更新日期:1981-08-01 00:00:00

  • Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes.

    abstract::Therapeutic gene delivery to hematopoietic stem cells (HSCs) holds great potential as a life-saving treatment of monogenic, oncologic, and infectious diseases. However, clinical gene therapy is severely limited by intrinsic HSC resistance to modification with lentiviral vectors (LVs), thus requiring high doses or repe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000040

    authors: Ozog S,Timberlake ND,Hermann K,Garijo O,Haworth KG,Shi G,Glinkerman CM,Schefter LE,D'Souza S,Simpson E,Sghia-Hughes G,Carillo RR,Boger DL,Kiem HP,Slukvin I,Ryu BY,Sorrentino BP,Adair JE,Snyder SA,Compton AA,Torbet

    更新日期:2019-10-17 00:00:00

  • Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia.

    abstract::The model of erythroleukemia caused by Spi-1/PU.1 transgenesis in mice is a multistage disease. A preleukemic step is characterized by an acute proliferation of proerythroblasts due to the arrest of differentiation provoked by Spi-1/PU.1. Later on, a blastic crisis occurs associated with somatic oncogenic mutations in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-110510

    authors: Monni R,Haddaoui L,Naba A,Gallais I,Arpin M,Mayeux P,Moreau-Gachelin F

    更新日期:2008-03-15 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Inhibitory effect of the transcription factor encoded by the mutant mi microphthalmia allele on transactivation of mouse mast cell protease 7 gene.

    abstract::The transcription factor encoded by the mi locus (MITF) is a transcription factor of the basic-helix-loop-helix zipper protein family. Mice of mi/mi genotype express a normal amount of abnormal MITF, whereas mice of tg/tg genotype do not express any MITFs due to the transgene insertional mutation. The effect of normal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.3.645

    authors: Ogihara H,Morii E,Kim DK,Oboki K,Kitamura Y

    更新日期:2001-02-01 00:00:00

  • Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.

    abstract::Naive and memory CD8(+) T cells can undergo programmed activation and expansion in response to a short T-cell receptor stimulus, but the extent to which in vitro programming can qualitatively substitute for an in vivo antigen stimulation remains unknown. We show that self-/tumor-reactive effector memory CD8(+) T cells...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-192419

    authors: Klebanoff CA,Yu Z,Hwang LN,Palmer DC,Gattinoni L,Restifo NP

    更新日期:2009-08-27 00:00:00

  • Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.

    abstract::A microperfusion system containing a glass capillary, the inner surface of which is coated with a phospholipid bilayer containing tissue factor, was used to explore the requirement for factors VIIa and Xa in the complex formed with the lipoprotein-associated coagulation inhibitor (LACI). Various combinations of factor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gemmell CH,Broze GJ Jr,Turitto VT,Nemerson Y

    更新日期:1990-12-01 00:00:00

  • CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

    abstract::The number of neutrophils in the blood is tightly regulated to ensure adequate protection against microbial pathogens while minimizing damage to host tissue. Neutrophil homeostasis in the blood is achieved through a balance of neutrophil production, release from the bone marrow, and clearance from the circulation. Acc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-177287

    authors: Eash KJ,Means JM,White DW,Link DC

    更新日期:2009-05-07 00:00:00

  • Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.

    abstract::Toll-like receptors (TLRs) are able to interact with pathogen-derived products and their signals induce the coordinated activation of innate and adaptive immune mechanisms. Dendritic cells (DCs) play a central role in these events. As the different TLRs are able to trigger MyD88/TRIF-dependent and -independent signali...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4015

    authors: Warger T,Osterloh P,Rechtsteiner G,Fassbender M,Heib V,Schmid B,Schmitt E,Schild H,Radsak MP

    更新日期:2006-07-15 00:00:00

  • Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells.

    abstract::Granulocyte colony-stimulating factor (G-CSF) may affect T-cell homeostasis by multiple mechanisms, inducing polarization of cytokine secretion, inhibition of T-cell proliferation, and enhancement of T-cell apoptosis. We analyzed the production of interleukin-10 (IL-10) and transforming growth factor-beta1 (TGF-beta1)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0291

    authors: Rutella S,Pierelli L,Bonanno G,Sica S,Ameglio F,Capoluongo E,Mariotti A,Scambia G,d'Onofrio G,Leone G

    更新日期:2002-10-01 00:00:00

  • Thrombocytopenia caused by the development of antibodies to thrombopoietin.

    abstract::Thrombocytopenia developed in some individuals treated with a recombinant thrombopoietin (TPO), pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Three of the subjects who developed severe thrombocytopenia were analyzed in detail to determine the cause of their thrombocytopenia. Ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.12.3241

    authors: Li J,Yang C,Xia Y,Bertino A,Glaspy J,Roberts M,Kuter DJ

    更新日期:2001-12-01 00:00:00

  • Selective suppression of IL-12 production by human herpesvirus 6.

    abstract::Human herpesvirus 6 (HHV-6) is a potentially immunosuppressive agent that has been suggested to act as a cofactor in the progression of HIV disease. Exposure of human macrophages to HHV-6A or HHV-6B profoundly impaired their ability to produce interleukin 12 (IL-12) upon stimulation with interferon-gamma (IFN-gamma) a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3152

    authors: Smith A,Santoro F,Di Lullo G,Dagna L,Verani A,Lusso P

    更新日期:2003-10-15 00:00:00

  • How I treat elderly patients with myeloma.

    abstract::The clinical approach to older patients with myeloma has to be modified to take into account comorbidities and the likelihood of higher treatment-related toxicity. Individualization of management and adequate supportive therapy are important to obtain the best response while minimizing adverse effects. Corticosteroids...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-163329

    authors: Mehta J,Cavo M,Singhal S

    更新日期:2010-09-30 00:00:00

  • Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa.

    abstract::Human B-cell lines were derived by limiting dilutions of Epstein-Barr virus (EBV) transformed peripheral B cells from a patient with an autoantibody against glycoprotein (GP)Ia/IIa, and manifesting defective collagen-induced platelet aggregation and a bleeding problem. Antibody-producing clones were selected for their...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deckmyn H,Zhang J,Van Houtte E,Vermylen J

    更新日期:1994-09-15 00:00:00

  • A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.

    abstract::An immunotoxin specific for human T lymphocytes was prepared by coupling an IgG2a anti-CD3 murine monoclonal antibody (64.1) to purified ricin A chain (64.1-A). Treatment of blood mononuclear cells with this immunotoxin at a concentration of 1.7 X 10(-9) mol/L for two hours at 37 degrees C in the presence of 20 mmol/L...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Martin PJ,Hansen JA,Vitetta ES

    更新日期:1985-10-01 00:00:00